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ABSTRACT
Introduction In the UK, a significant proportion of male 
remand prisoners have alcohol problems. Alcohol Brief 
Interventions (ABIs) are an effective component of a 
population-level approach to harmful and hazardous 
drinking. ABIs have been shown to reduce the aggregate 
level of alcohol consumed and therefore reduce harm to 
the individual and to others. However, in relation to remand 
prisoners, there is no evidence as to how effective ABIs 
could be. The aims of this study are therefore to explore 
the feasibility and acceptability of an ABI for adult male 
remand prisoners and to develop an ABI for this group to 
be piloted in a future trial.
Methods and analysis The study will comprise three 
stages. Stage 1: a cross-sectional survey of adult male 
remand and convicted prisoners (n=500) at one Scottish 
prison and one English prison will be undertaken to assess 
acceptability and feasibility of delivering an ABI, as well 
as prevalence rates of harmful, hazardous and dependent 
drinking. Stage 2: in-depth interviews will be conducted 
with a sample of remand prisoners (n=24) who undertook 
the survey (n=12 in Scotland; n=12 in England). Two 
focus groups (one in Scotland and one in England) with 
six to eight key stakeholders associated with alcohol-
related healthcare provision in prisons will be conducted 
to explore views on barriers, facilitators and levers to ABI 
delivery. Stage 3: through formal intervention mapping, the 
analysed data will inform the refinement of an acceptable 
ABI that is feasible to deliver to male remand prisoners.
Ethics and dissemination The project has been approved 
by the National Research Ethics Committee (NRES), 
National Offender Management System, Health Board 
Research and Development, Scottish Prison Service and 
ethics committee at The University of Edinburgh. Results 
will be published in peer-reviewed journals and presented 
at local, national and international conferences.
INTRODUCTION
Harmful use of alcohol has been identified as 
a causal factor in more than 200 diseases and 
injuries, with alcohol contributing to 5.1% 
of the global burden of disease and injury, 
as measured by Disability-Adjusted Life Years 
(DALYS).1 The impact of harmful alcohol 
can result in significant health, economic 
and social burden on individuals’ families 
and society as a whole.1 The evidence identi-
fies a link between health and crime,2 with a 
disproportionate level of health inequalities 
experienced by those individuals within the 
criminal justice system.
The delivery of Alcohol Brief Interven-
tions (ABIs), as a method of addressing 
alcohol-related harm, was set by the Scottish 
Government in 2008 as a national Health 
Improvement, Efficiency, Access and Treat-
ment (HEAT) target in three priority settings. 
The target evolved to become a HEAT 
standard for 2011–2013 and beyond, with 
National Health Service (NHS) boards and 
Alcohol and Drug Partnerships being respon-
sible for its delivery in at least 90% of the 
priority settings of accident and emergency, 
primary care and antenatal care, with other 
settings accounting for the remaining 10%.3 
In the recent local delivery plan standard, 
priority settings will account for 80% of ABI 
delivery, with wider settings such as prisons 
comprising the remaining 20%.4 Similarly, in 
England, Screening and Brief Interventions 
(SBIs) form part of The National Institute for 
Health and Care Excellence (NICE) quality 
standards5 with the opportunistic delivery of 
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Strengths and limitations of this study
 ► The first study to undertake Alcohol Brief 
Intervention development and feasibility in male 
remand prisoners.
 ► Prison staff and peer prisoners were involved in the 
recruitment process.
 ► Female remand prisoners were not recruited to the 
study.
 ► Those who could not understand or speak English 
to enable consent were unable to participate in 
the study and may limit the generalisability of the 
findings.
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SBIs for adults drinking at harmful or hazardous levels as 
a role for health and social care staff.
Background
There is robust evidence by way of systematic reviews 
and meta-analyses to indicate that ABIs are effective in 
reducing alcohol consumption among hazardous and 
harmful drinkers within healthcare settings.6 A Cochrane 
collaboration systematic review of 29 primary care trials 
reported that ABIs delivered to patients were associ-
ated with a statistically significant reduction equivalent 
to four or five units a week at 1 year, in comparison to 
controls.7 Nevertheless, there are weaknesses within the 
current evidence base: the majority of studies have been 
conducted in primary care; most trials have focused on 
middle-aged male drinkers; the optimal intensity and 
specific theoretical underpinnings of ABIs remains 
unclear.7 The need for ABIs to be tailored specifically 
for the prison population is warranted to ensure they 
are relevant and acceptable to male remand prisoners.8 
A recent literature review of prison-based interventions 
identified 28 studies between 1995 and 2009. These were 
largely based in the USA with a focus on young offenders 
and women,9 of which only one related to ABIs and 
targeted women prisoners. A more recent rapid system-
atic review identified no UK studies and only three from 
the USA of which none was remand focused.10 Likewise, 
to our knowledge there are no evaluation studies of ABIs 
involving male remand prisoners in the UK.
Globally, there are over 10 million people incarcerated, 
with prisoners bearing a substantial burden of communi-
cable and non-communicable diseases.11 Since the 1940s, 
there has been an increasing trend in the number of indi-
viduals incarcerated in the UK. In England and Wales 
between 1990 and 2015, there was a rise in the prison 
population of just over 90%, with 64% in Scotland and 
in Northern Ireland the increase was 68% between 2000 
and 2014/2015.12 The total UK prison population in 2016 
was just over 94 000 (95% male) with remand prisoners 
accounting for approximately 13%.12 More recently, a 
study of prisoners identified that 70% surveyed, reported 
to having been under the influence of alcohol when 
committing the offence for which they were incarcer-
ated.8 The prevalence of alcohol problems in adult male 
remand prisoners is very high, with around three-quarters 
identified as having an alcohol use disorder (AUD) and 
around 40% with possible alcohol dependence.8 13 Prison 
offers an opportunity for the identification, response 
and/or referral to treatment of those male remand pris-
oners who are consuming alcohol above recommended 
levels. Addressing alcohol harm in prisons can potentially 
reduce the risk of recidivism and reduce costs to society 
while tackling health inequalities.14 15 Health savings of 
£4.3 million and crime savings of £100 million per year 
can be as a result of appropriate alcohol interventions.16 
ABIs have been associated with improved outcomes 
such as health utility EuroQol Five Dimensions Ques-
tionnaire (EQ-5D), service utilisation and reduction in 
alcohol-related harm17 and are therefore of significant 
public health importance. However, access to ‘main-
stream’ prison-based alcohol services such as alcohol 
screening, interventions, treatment and referral into 
additional services is typically not possible. This is due to 
the relatively short period of time remand prisoners are 
incarcerated, with those both unconvicted and convicted 
and unsentenced spending an average of 9 weeks in 
custody awaiting trial and/or sentencing. Approximately 
25% of remand prisoners return to the community either 
as a result of being acquitted or receiving a non-custodial 
sentence. For these individuals, receiving an ABI as part 
of ‘Through the Gate’ or ‘Healthcare Through Care’ 18 19 
could offer an important ‘teachable moment’, particu-
larly if the ABI had a follow-on element. With the average 
prison sentence 16.2 months (56.8 months for indictable 
offences),20 the impact of an ABI delivered to sentenced 
prisoners while previously on remand is less clear.
From the UK evidence, it is clear that those in contact 
with the criminal justice system are drinking at risky levels. 
In comparison to 25% of the general population,21 22 we 
know that in the criminal justice system, 64% of young 
people, 53%–69% in the probation setting, 95% in the 
magistrate court setting, 64%–88% of adults in the police 
custody setting and 51%–83% in the prison system are 
classified as risky drinkers.23 It is also noted that pris-
oner drinking norms differ widely to that of community 
consumption patterns.24 25
Alcohol-related crime in England and Wales is esti-
mated to cost society £11 billion (2010–2011 costs). The 
association between alcohol use and crime is well docu-
mented.26–29 Amount drank, pattern of drinking, context 
and individual elements have been identified as interac-
tional influencing factors.30 However, both long-term and 
short-term savings have been evidenced, with cost-effec-
tive early intervention to reduce alcohol use.31
There is limited evidence as to the effectiveness, 
optimum timing of delivery, recommended length, 
content, implementation, economic benefit and 
follow-up of ABIs in the prison setting for male remand 
prisoners.10 32 This proposed early phase work is needed 
to adapt and develop a theoretically based self-efficacy 
enhancing ABI for use with male remand prisoners. 
There is also a need to establish whether such an inter-
vention would be acceptable to male remand prisoners. 
Lack of sufficient early phase work risks an intervention 
that is poorly specified, lacks or has a weak, theoretical 
base and is less likely to deliver the desired outcomes.
This study will develop an ABI that is acceptable for 
delivery to male remand prisoners who have been iden-
tified as drinking alcohol at a level that is causing, or has 
caused, them harm (harmful or hazardous consumption) 
as defined by the WHO.33 The study will also measure 
how feasible it is to deliver this intervention in the prison 
setting to male remand prisoners. The work is of impor-
tance to fill existing gaps in this area. We currently do 
not know what ‘type’ of ABI is needed or if it is accept-
able to the male remand prisoner population. We are 
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also unsure as to the issues surrounding the feasibility of 
delivering such an intervention, and by whom, as well as 
follow-ups. This early phase study sets out to address these 
questions. The proposed ABI that will be developed from 
this early phase study will focus on enhancing self-efficacy 
with the aim of increasing drinking refusal self-efficacy. 
Self-efficacy derives from social cognitive theory34 and has 
been identified as an important determinant of health 
behaviour, future health behaviour and health behaviour 
change. The four primary sources of self-efficacy informa-
tion (that can be targeted) are performance attainment, 
vicarious experiences, verbal persuasion and physiological 
state.34 Self-efficacy enhancing ABIs have been adapted in 
a range of health settings35–37 and used by the principal 
investigator (PI) (AH) in two of these studies. The inter-
vention here will be adapted and tailored for the unique 
circumstances of this group (male remand prisoners 
within a criminal justice setting) from an existing theo-
retically mapped self-efficacy enhancing ABI.35 38 39 The 
development of an acceptable ABI will then enable us to 
undertake a future pilot to test the intervention, followed 
by a definitive randomised controlled trial (RCT) to 
evaluate efficacy and cost-effectiveness and ultimately an 
implementation study.
Aim
The aims of this study are to explore the feasibility and 
acceptability of an ABI for adult male remand prisoners, 
to develop an appropriate ABI for adult male remand 
prisoners and a protocol for a multicentre randomised 
pilot study.
The specific objectives are:
 ► to identify the prevalence of self-reported hazardous/
harmful alcohol consumption in adult male 
prisoners as identified by the Alcohol Use Disorders 
Identification Test (AUDIT) including reported 
views/personal experiences of ABIs delivered in 
prisons with acceptability of participation in a future 
ABI research study with follow-up;
 ► to explore adult male remand prisoners perspectives 
in relation to their beliefs and perceptions about 
their alcohol use, views regarding the acceptability 
of receiving an ABI while on remand, experiences 
of engaging with health professionals in prisons in 
relation to their alcohol use, the nature of this, the 
perceived impact and outcome of it and perceptions 
of acceptable alcohol screening, intervention 
delivery points and techniques, methods of delivery 
and by whom this should be delivered;
 ► to explore prison stakeholders’ perceived feasibility 
and acceptability of an ABI for adult male remand 
prisoners among key stakeholders with a particular 
focus on their insights and experiences regarding 
the delivery of ABIs in prisons, perceptions of when, 
where and how in the current system, is the best 
place to screen and carry out ABI delivery and by 
whom, perceived mechanisms, processes, structures, 
training, cost, required to ensure feasibility of ABI 
delivery from male remand prisoners, perceived 
views on resources and timing of delivery within 
existing workloads and priorities, perceived views on 
barriers, facilitators and levers to delivery (individual 
and organisational);
 ► to identify what an adapted intervention mapped 
self-efficacy enhancing ABI would comprise, based 
on the data collected and analysed in stage 1 and 
stage 2.
METHODS AND ANALYSIS
The project will align to the early phase of the Medical 
Research Council’s (MRC) framework for the devel-
opment and evaluation of complex interventions.40 
Comprising three stages, a mixed-methods approach will 
be used with separate recruitment for prison stakeholders 
in stage 2. The data collection commenced June 2016 and 
will continue until January 2017.
Participants and setting
For stage 1 (remand and non-remand) and stage 2 
(remand prisoners) a purposive sample of male prisoners 
aged 18 and over who are currently imprisoned/detained 
within one Scottish prison within the Scottish Prison 
Service (SPS) prison estates and one English prison within 
the National Offender Management System (NOMS) will 
be recruited. To increase representativeness of prisons 
across the prison estate, we will aim to include two prisons 
with a range of prisoner categories and regimes. We will 
seek guidance from colleagues in criminal justice, NOMS 
and SPS to identify two appropriate prisons. Prison stake-
holder participants for stage 2 will be those involved in 
the delivery of alcohol-related healthcare in prisons. They 
will be identified by the study advisory group as well as 
through existing networks.
Prison data collection preparation
We will work closely with prison staff to understand the 
daily routines, lockdowns and visiting times. In advance, 
we will also identify locations for interviews to take 
place and procedures for research assistants (RAs) to be 
escorted to minimise disruption and maximise recruit-
ment. Following discussions with the prison sites, it is 
estimated that prisoner data collection will take 4 to 5 
months.
Stage 1: prisoner participant inclusion criteria
We will recruit male remand and non-remand prisoners 
aged 18 years and over, who have been detained within 
one SPS Scottish prison study site and one NOMS English 
prison study site. They will have been incarcerated for 3 
months or less and be willing to provide informed consent.
Stage 2: prisoner participant inclusion criteria
For stage 2, we will recruit male remand prisoners aged 
18 years and over who have participated in the stage 1 
survey and who have self-reported scores of 8 or over on 
the AUDIT41 and willing to provide continued informed 
consent.
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Stages 1 and 2: prisoner participant exclusion criteria
Excluded individuals will comprise those unable to 
consent or deemed unable to make an informed decision 
regarding consent, and those considered by prison staff 
to be at risk of harm to self and to others. Specifically 
excluded will be those unable to give informed consent 
or deemed incompetent/unable to make an informed 
decision regarding consent, those posing a risk to self 
and/or others including on suicide risk management 
(act to care) or at risk due to being on any substance. 
Also excluded will be any prisoner subject to rule 41 or 95 
(rules set out for the management of prisoners and young 
offender’s institutions in Scotland)42 or any prisoner on 
special security measures.
The prison staff will be trained by the researchers to 
understand the inclusion and exclusion criteria and will 
identify any inappropriate participants.
Stage 2: stakeholder inclusion criteria
Involved in the delivery of alcohol-related healthcare in 
prisons (implementation, delivery, training, monitoring 
and/or commissioning) and willing to provide informed 
written consent.
Stage 2: stakeholder exclusion criteria
Role does not involve the delivery of alcohol-related 
healthcare in prisons (implementation, delivery, training, 
monitoring and/or commissioning).
Stage 1
Cross-sectional survey
Recruitment and consent
Prison staff and peer prisoners will provide potential 
participants with a short verbal account of the research 
study, together with a copy of the participant information 
sheet and a reply slip, in a sealable envelope during or 
after their prison induction. We will engage with service 
users through a community justice charity organisation 
when developing the study information leaflets and 
consent forms. The RAs will obtain informed written 
consent from potential participants. We will record the 
number of prisoners who are unable to consent due to 
language/literacy/cognitive impairment. For remand 
prisoners only, consent will also cover participation in 
both the survey (stage 1) and the in-depth interviews, if 
invited to take part in these (stage 2).
Study design
We will conduct an interviewer-led cross-sectional survey, 
delivered by the study RAs. Based on previous studies, we 
anticipate recruiting 500 participants (n=250 at each site) 
of that approximately 100 (n=50 at each site) will be male 
remand prisoners.1 2 A sample size of 100 remand pris-
oners ensures that the half width of a two-sided 95% CI 
for a continuous outcome (eg, the total AUDIT score) 
is no more than 0.2 times the SD; and the half width of 
a two-sided 95% CI for a proportion (eg, the prevalence 
of drinking at harmful, hazardous and dependent levels) 
is no more than 10%. A sample size of 400 convicted 
prisoners ensures that the half width of a two-sided 95% 
CI for a continuous outcome (eg, the total AUDIT score) 
is no more than 0.1 times the SD; and the half width of a 
two-sided 95% CI for a proportion (eg, the prevalence of 
drinking at harmful, hazardous and dependent levels) is 
no more than 5%.
Questions used in previous surveys will be adapted 
for use.43 44 Basic demographic data, ethnicity, nature of 
charge and data from the 10-time screening instrument 
AUDIT will be recorded. The AUDIT is considered to 
be the gold standard for alcohol screening in healthcare 
settings.41 The AUDIT can be scored between 0 and 40. 
A score of 8+ is referred to as a ‘positive screen’ and 
indicates an alcohol use disorder; hazardous drinking 
(score of 8–15), harmful drinking (16-19) or probable 
dependent drinking (20+). A score of 8 or more out of a 
possible 40 on the AUDIT is able to detect genuine exces-
sive drinkers and to exclude false cases with sensitivity and 
specificity of 92% and 94%, respectively.45
To explore the acceptability of intervening, the ques-
tionnaire will ask participants how useful they would find a 
range of interventions, experiences of ever have receiving 
alcohol advice/information, their willingness to receive an 
intervention and whether in principle they would be willing 
to participate in an ABI research study with follow-up 
contact. Each interview survey document will have a unique 
study identifier (ID). The survey will be conducted where 
applicable privately in an identified meeting room within 
the prison. Questions will be read out to the participant and 
their answers recorded onto a hard copy of the survey.
Data entry and analysis
Quantitative data from the questionnaire will be coded 
and entered into SPSS software V.19.0. Data cleaning will 
be undertaken to identify and address any incomplete, 
incorrect or inaccurate data. The data will be cross-checked 
against the hard data. Descriptive statistics and 95% CIs will 
be used to summarise the data and inform the design of 
a potential future pilot trial. The quantitative analysis will 
be stratified such that the analysis will be conducted in 
the remand and non-remand prisoner groups separately. 
Variables will be classified and described using frequency 
tables, mean, median and SD. The prevalence of drinking 
at harmful, hazardous and dependent levels and corre-
sponding 95% CIs will be calculated.
Open-ended responses from the survey will be coded 
into appropriate response categories. Where comments 
include multiple topics, we will code these into multiple 
categories. For those open-ended question responses 
that are illustrative, we will maintain these as verbatim 
responses to highlight key findings.
Stage 2
Prisoner interviews and stakeholder focus groups
Prisoner interviews
Study design: In-depth face-to face interviews with a subsa-
mple of male remand prisoners who completed the 
stage 1 survey will be conducted. A sampling matrix will 
 on 7 D
ecem
ber 2018 by guest. P
rotected by copyright.
http://bm
jopen.bm
j.com
/
B
M
J O
pen: first published as 10.1136/bm
jopen-2016-014561 on 4 M
ay 2017. D
ow
nloaded from
 
 5Holloway A, et al. BMJ Open 2017;7:e014561. doi:10.1136/bmjopen-2016-014561
Open Access
be developed to inform a purposive sampling strategy 
to ensure representation in relation to range of AUDIT 
scores, age and previous experience of having an ABI. 
The RAs will liaise with the gatekeepers at each prison site 
to arrange appropriate dates and times for the in-depth 
interviews. For those who may have been released before a 
date and time has been arranged, there will be no further 
contact. A verbal recap with the participant information 
sheet will be undertaken by the RA and consent recon-
firmed with opportunity for any questions to be answered.
Twelve male remand prisoners will be interviewed 
from each of the two study sites. Setting of the interviews 
will be as stage 1. The interviews will last approximately 
45–60 min and will be digitally recorded at both study sites. 
Due to restrictions on the use of digital recorders, request 
and approval procedures for use of digital recorders 
will be sought at each study site. An interview schedule 
informed by the data collected from the stage 1 survey 
will guide the discussion. Topics will include participants’ 
alcohol-related beliefs, experiences of engagement with 
health professionals or prison staff in relation to their 
alcohol use or any other individual while they have been 
in prison, perceived impact and outcome of this. We will 
also explore with them how best to maintain contact if 
they were to have participated in a follow-up trial. Each 
participant will also be shown an A4 page infographic 
outlining the key components and nature of an ABI. We 
will use this opportunity to explore their perceptions of 
the intervention content, intervention points and tech-
niques to establish adaptations required to the existing 
self-efficacy enhancing ABI.
Data entry and analysis: The digitally recorded interviews 
will be anonymised and transcribed. Thematic analysis 
techniques using NViVo V.10 will be employed to produce 
initial codes categorising the content of each transcript. 
These codes will then be iteratively refined to produce 
emergent themes. Divergent and similar themes across 
interviews will be examined, comparing experiences and 
views regarding the acceptability, implementation, mech-
anisms, content and processes of an ABI and its delivery.
Stakeholder focus groups
Recruitment and consent: Key stakeholders at each study site 
will be sent an introductory letter together with a partic-
ipant information leaflet and consent form. A purposive 
sampling strategy will be adopted to ensure a range of 
professions, organisations and individuals are included. 
We anticipate that these are likely to include: prison 
nurses, commissioners, prison officers, prison health 
centre managers, external service provides, alcohol 
and drug partnerships in Scotland and equivalent in 
England. Where the stakeholder is an organisation, they 
will be asked to identify the most relevant individual to 
participate. The letter will ask that they contact the RA 
if they wish to participate and/or ask any questions that 
they may have about the study. The RA will gain written 
consent from those agreeing to participate prior to the 
focus group taking place.
Study design: Focus groups will take place with key stake-
holders (n=6–8) from each study site and will be held 
in a location at a date and time convenient for partici-
pants. The RAs for each study site will facilitate each focus 
group, each have experience in undertaking qualitative 
research and will also take observational notes. A focus 
group topic guide will be used to structure the focus 
group. This will be informed by the data collected in stage 
1 and qualitative data collected in stage 2 male remand 
prisoner interviews. The focus groups will last approxi-
mately 60 min.
Data entry and analysis: Focus groups will be digitally 
recorded, transcribed and analysed as per stage 2 male 
remand prisoner interviews. We will also be cognisant 
of the particular nuances of focus group data analysis 
and the need to focus on the intention and purpose of 
the study to ensure that we can make sense of the large 
amounts of data that can be generated.46
Stage 3
Adaptation of intervention
Intervention mapping will be used to refine and develop 
an existing self-efficacy enhancing ABI47 to reduce 
reported levels of alcohol consumption in male remand 
prisoners. Using an existing self-efficacy enhancing ABI 
framework, detailed mapping will be undertaken with 
an intervention specification developed, matrix of objec-
tives and determinants identified and an implementation 
strategy produced. Members of the research study team 
will undertake this activity with input from the advisory 
group.
Ethical considerations
Multisite ethical approval was sought through the Inte-
grated Research Application System (IRAS), and ethical 
approval was obtained from NRES, NOMS, R&D SPS, 
School of Health  in Social Science, The University of Edin-
burgh. It is also important to ensure that the researchers 
are fully supported and cognisant of the issues involved 
in working within a prison environment. To address this, 
they will undertake prison delivered training, which will 
educate them on relevant protocols and risk assessment 
tools that the prisons use. The training is typical of that 
given to staff working in the prisons and includes for 
example personal protection training, fire safety training, 
hostage training, professional boundaries and suicide 
awareness and prevention. They will be provided with a 
personal alarm, will be accompanied by staff wherever 
necessary and will complete university risk assessments. 
During fieldwork, the researchers will have regular 
debriefing sessions with the PI (AH) and coinvestigator 
(DNB), will speak to each other weekly and will keep 
research diaries.
Consent
For this study, we consider valid consent to be under-
pinned by adequate information being provided to 
the potential study participant, and that they have the 
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capacity to decide whether or not they want to take part. 
Drawing from the Royal College of Nursing guidance on 
informed consent in health and social care research,48 a 
capable person is defined as one who will:
 ► understand the purpose and nature of the research
 ► understand what the research involves, its benefits 
(or lack of benefits), risks and burdens
 ► understand the alternatives to taking part
 ► be able to retain the information long enough to 
make an effective decision
 ► be able to make a free choice
 ► be capable of making this particular decision at the 
time it needs to be made.
Freedom of consent can easily be undermined for 
prisoners and those in the criminal justice system, which 
means they may be more vulnerable to exploitation or 
abuse by researchers. For example, learning disabilities, 
illiteracy and language barriers are prevalent within these 
populations (www. prisonreformtrust. org. uk). Alongside 
the power differential between researcher and potential 
participant, particular care is needed to ensure that valid, 
freely given and fully informed consent can be achieved. 
We will train the researchers to use the Offender Health 
Research Network Toolkit that outlines a pathway to 
successfully undertake health research in the criminal 
justice system (www. ohrn. nhs. uk/ toolkit/). The expert 
advisory group will also provide support, while profes-
sional codes of ethics (Nursing and Midwifery Council) 
will guide the team to safeguard the civil rights of subjects. 
The team has experience of undertaking research with 
offenders and in criminal justice settings, for example, 
prisons, probation and addiction services.
Monitoring
We have convened an advisory group with terms of 
reference. The group will meet three times during the 
duration of the 18-month study to review progress of the 
project and to advise on engagement and dissemination.
Data management
To optimise the security of our data, a database will be held 
at each university site. All data will be treated confiden-
tially and stored securely and anonymously. Datasets will be 
created and maintained separate to participants’ non-iden-
tifiable research data, and linked using unique identifier 
code, during collection, storage, management and transfer 
processes. All data will be accessible to project staff only. This 
system will be used for both hard copy and electronic files, 
for example, questionnaires, interview schedules, audio 
recordings, transcripts and database records. Any trans-
porting or transmitting of data will ensure that personal/
sensitive and wider data are transported separately to each 
other and in a secure manner. This will include transport 
from fieldwork sites to the research head office at The 
University of Edinburgh, or electronic transmission, if 
required. No personal data will be transferred outside the 
borders of the UK, or stored or collected on computer 
servers outside of UK borders. Any requirements to pass 
any personal data to another organisation will be approved 
by NHS Health Scotland in advance. The University of 
Edinburgh complies with the Data Protection Act 1998 and 
the University has a Digital Curation Centre that provides 
support and advice regarding data management planning 
(DMP) for researchers within the University. This enables 
researchers to undertake DMP according to the require-
ments stipulated by the major UK funders. Accordingly, we 
will work with the centre to build our DMP to ensure that 
we meet MRC requirements with regards to research integ-
rity and replication, ensuring research data and records 
are accurate, complete, authentic and reliable alongside 
increasing research efficiency, saving time and resources 
in the long term while enhancing data security and mini-
mising the risk of data loss.
Dissemination
Our dissemination plan includes local, national and inter-
national communication, and the dissemination strategy 
will be a key output of the advisory group in collabora-
tion with the research team. We will ensure that digital 
and media communication are utilised as part of the 
strategy. We will publish a full account of our research 
through open access peer-reviewed journal articles. Our 
outputs will be recorded on Researchfish. Findings of the 
study and the proposed pilot RCT will be disseminated 
to Health and Justice Teams at Scottish Government and 
Public Health England, the National Prisoner Healthcare 
Network (Scotland) and the WHO (Health in Prisons 
Programme Collaborating Centre). We will present our 
research at meetings/workshops/events of appropriate 
learned societies, for example, Scottish Alcohol Research 
Network, Scottish Health Action on Alcohol Problems and 
Offender Health Research Network. In addition, we will 
present our findings at national and international confer-
ences. We will work with press officers at The University 
of Edinburgh to publicise the results of our work to local, 
national and international news media including radio.
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